Physician compliance with guidelines for deep-vein thrombosis prevention in total hip and knee arthroplasty

References

• Geerts WH, Heit JA, Clagett GP, et al. Prevention of venous thromboembolism. Chest 2001;119(1 Suppl):132–75S
   Google Scholar
• Geerts WH, Pineo GF, Heit JA, et al. Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004;126(3 Suppl):338–400S
   Google Scholar
• Nicolaides AN, Breddin HK, Fareed J, et al; Cardiovascular Disease Educational and Research Trust and the International Union of Angiology. Prevention of venous thromboembolism. International Consensus Statement. Guidelines compiled in accordance with the scientific evidence. Int Angiol 2001;20:1–37
   Google Scholar
• Davis DA, Thomson MA, Oxman AD, Haynes RB. Changing physician performance. A systematic review of the effect of continuing medical education strategies. JAMA 1995;274:700–5
   Google Scholar
• Kucher N, Koo S, Quiroz R, et al. Electronic alerts to prevent venous thromboembolism among hospitalized patients. N Engl J Med 2005;352:969–77
   PubMed Web of Science ®Google Scholar
• Soumerai SB, Avorn J. Principles of educational outreach (‘academic detailing’) to improve clinical decision making. JAMA 1990;263:549–56
   PubMed Web of Science ®Google Scholar
• Williams HR, Macdonald DA. Audit of thromboembolic prophylaxis in hip and knee surgery. Ann R Coll Surg Engl 1997;79:55–7
   PubMed Web of Science ®Google Scholar
• Mosen D, Elliott CG, Egger MJ, et al. The effect of a computerized reminder system on the prevention of postoperative venous thromboembolism. Chest 2004;125:1635–41
   PubMed Web of Science ®Google Scholar
• Prevention of venous thromboembolism. International Consensus Statement (guidelines according to scientific evidence). Int Angiol 1997;16:3–38
   PubMed Web of Science ®Google Scholar
• Clagett GP, Anderson FA Jr, Geerts W, et al. Prevention of venous thromboembolism. Chest 1998;114(5 Suppl):531–60S
   Google Scholar
• Clagett GP, Anderson FA Jr, Heit J, et al. Prevention of venous thromboembolism. Chest 1995;108(4 Suppl):312–34S
   Google Scholar
• Second Thromboembolic Risk Factors (THRiFT II) Consensus Group. Risk of and prophylaxis for venous thromboembolism in hospital patients. Phlebology 1998;13:87–97
   Google Scholar
• Anderson FA Jr, Hirsh J, White K, Fitzgerald RH Jr; Hip and Knee Registry Investigators. Temporal trends in prevention of venous thromboembolism following primary total hip or knee arthroplasty 1996–2001: findings from the Hip and Knee Registry. Chest 2003;124(6 Suppl):349–56S
   Google Scholar
• Schonenberg D, van Meeteren M, Nelissen RG, et al. Thrombosis prevention in orthopaedic surgery: clinical practice in the Netherlands in 2002 [in Dutch]. Ned Tijdschr Geneeskd 2003;147:1856–60
   PubMedGoogle Scholar
• Stratton MA, Anderson FA, Bussey HI, et al. Prevention of venous thromboembolism: adherence to the 1995 American College of Chest Physicians consensus guidelines for surgical patients. Arch Intern Med 2000;160:334–40
   PubMed Web of Science ®Google Scholar
• Leclerc JR, Gent M, Hirsh J, et al. The incidence of symptomatic venous thromboembolism during and after prophylaxis with enoxaparin: a multi-institutional cohort study of patients who underwent hip or knee arthroplasty. Canadian Collaborative Group. Arch Intern Med 1998;158:873–8
   PubMed Web of Science ®Google Scholar
• White RH, Romano PS, Zhou H, et al. Incidence and time course of thromboembolic outcomes following total hip or knee arthroplasty. Arch Intern Med 1998;158:1525–31
   PubMed Web of Science ®Google Scholar
• White RH, Zhou H, Romano PS. Incidence of symptomatic venous thromboembolism after different elective or urgent surgical procedures. Thromb Haemost 2003;90:446–55
   Google Scholar
• Guyatt G, Schunemann H, Cook D, et al; American College of Chest Physicians. Grades of recommendation for antithrombotic agents. Chest 2001;119(1 Suppl):3–7S
   Google Scholar
• Ahmad HA, Geissler A, MacLellan DG. Deep venous thrombosis prophylaxis: are guidelines being followed? ANZ J Surg 2002;72:331–4
   Google Scholar
• Arnold DM, Kahn SR, Shrier I. Missed opportunities for prevention of venous thromboembolism: an evaluation of the use of thromboprophylaxis guidelines. Chest 2001;120: 1964–71
   Google Scholar
• Eikelboom JW, Mazzarol A, Quinlan DJ, et al; The American College of Chest Physicians. Thromboprophylaxis practice patterns in two Western Australian teaching hospitals. Haematologica 2004;89:586–93
   Google Scholar
• Vallano A, Arnau JM, Miralda GP, Perez-Bartoli J. Use of venous thromboprophylaxis and adherence to guideline recommendations: a cross-sectional study. Thromb J 2004;2: 3
   Google Scholar
• Wells PS, Holbrook AM, Crowther NR, Hirsh J. Interactions of warfarin with drugs and food. Ann Intern Med 1994;121:676–83
   PubMed Web of Science ®Google Scholar
• Wittkowsky AK, Devine EB. Frequency and causes of overanti-coagulation and underanticoagulation in patients treated with warfarin. Pharmacotherapy 2004;24:1311–16
   PubMed Web of Science ®Google Scholar
• Harrison L, Johnston M, Massicotte MP, et al. Comparison of 5-mg and 10-mg loading doses in initiation of warfarin therapy. Ann Intern Med 1997;126:133–6
   PubMed Web of Science ®Google Scholar
• Loebstein R, Yonath H, Peleg D, et al. Interindividual variability in sensitivity to warfarin – Nature or nurture? Clin Pharmacol Ther 2001;70:159–64
   PubMed Web of Science ®Google Scholar
• Kent DL, Vermes D, McDonell M, et al. A model for planning optimal follow-up for outpatients on warfarin anticoagulation. Warfarin Optimal Outpatient Follow-up Study Group. Med Decis Making 1992;12:132–41
   Web of Science ®Google Scholar
• Dahl OE, Gudmundsen TE, Haukeland L. Late occurring clinical deep vein thrombosis in joint-operated patients. Acta Orthop Scand 2000;71:47–50
   Google Scholar
• Harris WH, Salzman EW, DeSanctis RW, Coutts RD. Prevention of venous thromboembolism following total hip replacement. Warfarin vs dextran 40. JAMA 1972;220: 1319–22
   Google Scholar
• Paiement GD, Wessinger SJ, Hughes R, Harris WH. Routine use of adjusted low-dose warfarin to prevent venous thrombo-embolism after total hip replacement. J Bone Joint Surg Am 1993;75:893–8
   PubMed Web of Science ®Google Scholar
• Poller L. A simple nomogram for the derivation of international normalised ratios for the standardisation of prothrombin times. Thromb Haemost 1988;60:18–20
   PubMed Web of Science ®Google Scholar
• Eikelboom JW, Quinlan DJ, Douketis JD. Extended-duration prophylaxis against venous thromboembolism after total hip or knee replacement: a meta-analysis of the randomised trials. Lancet 2001;358:9–15
   Google Scholar
• Hull RD, Pineo GF, Stein PD, et al. Extended out-of-hospital low-molecular-weight heparin prophylaxis against deep venous thrombosis in patients after elective hip arthroplasty: a systematic review. Ann Intern Med 2001;135:858–69
   PubMed Web of Science ®Google Scholar
• Bergqvist D, Jonsson B. Cost-effectiveness of prolonged administration of a low molecular weight heparin for the prevention of deep venous thrombosis following total hip replacement. Value Health 1999;2:288–94
   PubMedGoogle Scholar
• Dahl OE, Pleil AM. Investment in prolonged thromboprophylaxis with dalteparin improves clinical outcomes after hip replacement. J Thromb Haemost 2003;1:896–906
   PubMed Web of Science ®Google Scholar
• Friedman RJ, Dunsworth GA. Cost analyses of extended prophylaxis with enoxaparin after hip arthroplasty. Clin Orthop Relat Res 2000;370:171–82
   PubMed Web of Science ®Google Scholar